Midterm risk of cancer with metal-on-metal hip replacements not increased in a Finnish population

Background and purpose — Metal-on-metal (MoM) total hip arthroplasty (THA) and hip resurfacing arthroplasty (HRA) have been widely used during the early 21st century. We assessed the midterm risk of cancer of patients treated with modern MoM hip implants compared with patients with non-MoM hip impla...

Full description

Bibliographic Details
Main Authors: Elina Ekman, Inari Laaksonen, Antti Eskelinen, Pekka Pulkkinen, Eero Pukkala, Keijo Mäkelä
Format: Article
Language:English
Published: Medical Journals Sweden 2018-09-01
Series:Acta Orthopaedica
Online Access:http://dx.doi.org/10.1080/17453674.2018.1487202
_version_ 1828429763060957184
author Elina Ekman
Inari Laaksonen
Antti Eskelinen
Pekka Pulkkinen
Eero Pukkala
Keijo Mäkelä
author_facet Elina Ekman
Inari Laaksonen
Antti Eskelinen
Pekka Pulkkinen
Eero Pukkala
Keijo Mäkelä
author_sort Elina Ekman
collection DOAJ
description Background and purpose — Metal-on-metal (MoM) total hip arthroplasty (THA) and hip resurfacing arthroplasty (HRA) have been widely used during the early 21st century. We assessed the midterm risk of cancer of patients treated with modern MoM hip implants compared with patients with non-MoM hip implants and the general Finnish population with special interest in soft tissue sarcomas and basalioma due to the findings of our previous report. Patients and methods — All large-diameter head MoM THAs and hip resurfacings performed in Finland between 2001 and 2010 were extracted from the Finnish Arthroplasty Register (10,728 patients). Patients who underwent conventional THA formed the non-MoM reference cohort (18,235 patients). Data on cancer cases up to 2014 were extracted from the Finnish Cancer Registry. The relative risk of cancer in the general population was expressed as the ratio of observed to expected number of cases, i.e., standardized incidence ratio (SIR). Poisson regression analysis was used to compare the cancer risk between the cohorts. The mean follow-up was 7.4 years (1–14) in the MoM cohort and 8.4 years (1–14) in the non-MoM cohort. Results — The overall risk of cancer in the MoM cohort was comparable to the general Finnish population (SIR 0.9, 95% CI 0.9–1.0). Risk of basalioma in the MoM cohort was higher than in the general Finnish population (SIR 1.2, CI 1.1–1.4) and higher than in the non-MoM cohort in the stratified regression analysis (RR 1.2, CI 1.0–1.4, p = 0.02). The SIR of soft-tissue sarcoma in the MoM cohort was 1.4 (CI 0.6–2.8); the incidence was same as in the non-MoM cohort. Interpretation — Metal-on-metal hip implants are not associated with an increased overall risk of cancer during midterm follow-up.
first_indexed 2024-12-10T17:38:00Z
format Article
id doaj.art-eb8e305ffd8f444c806c089ff755d004
institution Directory Open Access Journal
issn 1745-3674
1745-3682
language English
last_indexed 2024-12-10T17:38:00Z
publishDate 2018-09-01
publisher Medical Journals Sweden
record_format Article
series Acta Orthopaedica
spelling doaj.art-eb8e305ffd8f444c806c089ff755d0042022-12-22T01:39:28ZengMedical Journals SwedenActa Orthopaedica1745-36741745-36822018-09-0189557557910.1080/17453674.2018.14872021487202Midterm risk of cancer with metal-on-metal hip replacements not increased in a Finnish populationElina Ekman0Inari Laaksonen1Antti Eskelinen2Pekka Pulkkinen3Eero Pukkala4Keijo Mäkelä5Turku University HospitalTurku University HospitalCoxa Hospital for Joint ReplacementHelsinki UniversityUniversity of TampereTurku University HospitalBackground and purpose — Metal-on-metal (MoM) total hip arthroplasty (THA) and hip resurfacing arthroplasty (HRA) have been widely used during the early 21st century. We assessed the midterm risk of cancer of patients treated with modern MoM hip implants compared with patients with non-MoM hip implants and the general Finnish population with special interest in soft tissue sarcomas and basalioma due to the findings of our previous report. Patients and methods — All large-diameter head MoM THAs and hip resurfacings performed in Finland between 2001 and 2010 were extracted from the Finnish Arthroplasty Register (10,728 patients). Patients who underwent conventional THA formed the non-MoM reference cohort (18,235 patients). Data on cancer cases up to 2014 were extracted from the Finnish Cancer Registry. The relative risk of cancer in the general population was expressed as the ratio of observed to expected number of cases, i.e., standardized incidence ratio (SIR). Poisson regression analysis was used to compare the cancer risk between the cohorts. The mean follow-up was 7.4 years (1–14) in the MoM cohort and 8.4 years (1–14) in the non-MoM cohort. Results — The overall risk of cancer in the MoM cohort was comparable to the general Finnish population (SIR 0.9, 95% CI 0.9–1.0). Risk of basalioma in the MoM cohort was higher than in the general Finnish population (SIR 1.2, CI 1.1–1.4) and higher than in the non-MoM cohort in the stratified regression analysis (RR 1.2, CI 1.0–1.4, p = 0.02). The SIR of soft-tissue sarcoma in the MoM cohort was 1.4 (CI 0.6–2.8); the incidence was same as in the non-MoM cohort. Interpretation — Metal-on-metal hip implants are not associated with an increased overall risk of cancer during midterm follow-up.http://dx.doi.org/10.1080/17453674.2018.1487202
spellingShingle Elina Ekman
Inari Laaksonen
Antti Eskelinen
Pekka Pulkkinen
Eero Pukkala
Keijo Mäkelä
Midterm risk of cancer with metal-on-metal hip replacements not increased in a Finnish population
Acta Orthopaedica
title Midterm risk of cancer with metal-on-metal hip replacements not increased in a Finnish population
title_full Midterm risk of cancer with metal-on-metal hip replacements not increased in a Finnish population
title_fullStr Midterm risk of cancer with metal-on-metal hip replacements not increased in a Finnish population
title_full_unstemmed Midterm risk of cancer with metal-on-metal hip replacements not increased in a Finnish population
title_short Midterm risk of cancer with metal-on-metal hip replacements not increased in a Finnish population
title_sort midterm risk of cancer with metal on metal hip replacements not increased in a finnish population
url http://dx.doi.org/10.1080/17453674.2018.1487202
work_keys_str_mv AT elinaekman midtermriskofcancerwithmetalonmetalhipreplacementsnotincreasedinafinnishpopulation
AT inarilaaksonen midtermriskofcancerwithmetalonmetalhipreplacementsnotincreasedinafinnishpopulation
AT anttieskelinen midtermriskofcancerwithmetalonmetalhipreplacementsnotincreasedinafinnishpopulation
AT pekkapulkkinen midtermriskofcancerwithmetalonmetalhipreplacementsnotincreasedinafinnishpopulation
AT eeropukkala midtermriskofcancerwithmetalonmetalhipreplacementsnotincreasedinafinnishpopulation
AT keijomakela midtermriskofcancerwithmetalonmetalhipreplacementsnotincreasedinafinnishpopulation